FDA Drug Application (022100) for AZOR by DAIICHI SANKYO

Back to FDA Applications sponsored by DAIICHI SANKYO

Application Number022100
Product Number001
FormTABLET;ORAL
DosageEQ 5MG BASE;20MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameAZOR
Active IngredientAMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL

Active IngredientCount
List of drugs with Active Ingredient AMLODIPINE BESYLATE21
List of drugs with Active Ingredient OLMESARTAN MEDOXOMIL11


Back to FDA Applications sponsored by DAIICHI SANKYO